SRF Ltd’s September quarter (Q2FY27) results reveal that pain for the specialty chemicals business has persisted. Although the management is rooting for a better H2, the Street is not fully convinced. While the SRF stock recovered on Friday after hitting a new 52-week low of ₹2,178.30 on the National Stock Exchange on Thursday, it has declined 23% so far in CY26. In Q2, revenue rose 35% year-on-year to ₹4,904 crore, falling 3% sequentially.